Overview

Dosing Intervals of Opioid Medication for Chronic Pain

Status:
Withdrawn
Trial end date:
2020-03-08
Target enrollment:
Participant gender:
Summary
This study is to determine the feasibility of an n-of-1, randomized, double blind, placebo controlled case series to examine effects of extended release opioids when used at intervals shorter than recommended by the manufacturer by people with chronic pain.
Phase:
Phase 4
Details
Lead Sponsor:
University Health Network, Toronto
Collaborator:
Canadian Society of Hospital Pharmacists
Treatments:
Analgesics, Opioid
Hydromorphone
Morphine
Oxycodone